搜档网
当前位置:搜档网 › HY-P0166A_23483_MCE

HY-P0166A_23483_MCE

HY-P0166A_23483_MCE
HY-P0166A_23483_MCE

Data Sheet

BIOLOGICAL ACTIVITY:

Alexamorelin Met 1 is one of the metabolites of alexamorelin. The heptapeptide Ala?His?D ?2?methyl?Trp?Ala?Trp?D ?Phe?Lys?NH 2(Alexamorelin) is a synthetic molecule which inhibits growth hormone secretagogue binding in vitro .

Product Name:Alexamorelin Met 1Cat. No.:

HY-P0166A Molecular Formula:N/A Molecular Weight:N/A Target:GHSR

Pathway:GPCR/G Protein Solubility:

DMSO

Caution: Product has not been fully validated for medical applications. For research use only.

Tel: 609-228-6898 Fax: 609-228-5909 E-mail: tech@https://www.sodocs.net/doc/105213756.html,

Address: 1 Deer Park Dr, Suite Q, Monmouth Junction, NJ 08852, USA

Certificate of Analysis

PHYSICAL AND CHEMICAL PROPERTIES

Molecular Formula:N/A Molecular Weight:N/A Storage:

Powder -20°C 3 years 4°C 2 years In solvent

-80°C 6 months -20°C

1 month

Chemical Structure:

ANALYTICAL DATA

Appearance:White to off-white (Solid)LCMS:Consistent with structure Purity (LCMS):99.82%

Conclusion:

The product has been tested and complies with the given specifications.

Product Name:Alexamorelin Met 1Cat. No.:HY-P0166A Batch No.:23483

Chemical Name:

(D-Mrp)-Ala-Trp-(D-Phe)

Caution: Product has not been fully validated for medical applications. For research use only.

Tel: 609-228-6898 Fax: 609-228-5909 E-mail: tech@https://www.sodocs.net/doc/105213756.html,

Address: 1 Deer Park Dr, Suite Q, Monmouth Junction, NJ 08852, USA

Safety Data Sheet Revision Date:May-24-2017

Print Date:May-24-2017

1. PRODUCT AND COMPANY IDENTIFICATION

1.1 Product identifier

Product name :Alexamorelin Met 1

Catalog No. :HY-P0166A

CAS No. :None

1.2 Relevant identified uses of the substance or mixture and uses advised against

Identified uses :Laboratory chemicals, manufacture of substances.

1.3 Details of the supplier of the safety data sheet

Company:MedChemExpress USA

Tel:609-228-6898

Fax:609-228-5909

E-mail:sales@https://www.sodocs.net/doc/105213756.html,

1.4 Emergency telephone number

Emergency Phone #:609-228-6898

2. HAZARDS IDENTIFICATION

2.1 Classification of the substance or mixture

Not a hazardous substance or mixture.

2.2 GHS Label elements, including precautionary statements

Not a hazardous substance or mixture.

2.3 Other hazards

None.

3. COMPOSITION/INFORMATION ON INGREDIENTS

3.1 Substances

Synonyms:(D?Mrp)?Ala?Trp?(D?Phe)

Formula:N/A

Molecular Weight:N/A

CAS No. :None

4. FIRST AID MEASURES

4.1 Description of first aid measures

Eye contact

Remove any contact lenses, locate eye-wash station, and flush eyes immediately with large amounts of water. Separate eyelids with fingers to ensure adequate flushing. Promptly call a physician.

Skin contact

Rinse skin thoroughly with large amounts of water. Remove contaminated clothing and shoes and call a physician.

Inhalation

Immediately relocate self or casualty to fresh air. If breathing is difficult, give cardiopulmonary resuscitation (CPR). Avoid mouth-to-mouth resuscitation.

Ingestion

Wash out mouth with water; Do NOT induce vomiting; call a physician.

4.2 Most important symptoms and effects, both acute and delayed

The most important known symptoms and effects are described in the labelling (see section 2.2).

4.3 Indication of any immediate medical attention and special treatment needed

Treat symptomatically.

5. FIRE FIGHTING MEASURES

5.1 Extinguishing media

Suitable extinguishing media

Use water spray, dry chemical, foam, and carbon dioxide fire extinguisher.

5.2 Special hazards arising from the substance or mixture

During combustion, may emit irritant fumes.

5.3 Advice for firefighters

Wear self-contained breathing apparatus and protective clothing.

6. ACCIDENTAL RELEASE MEASURES

6.1 Personal precautions, protective equipment and emergency procedures

Use full personal protective equipment. Avoid breathing vapors, mist, dust or gas. Ensure adequate ventilation. Evacuate personnel to safe areas.

Refer to protective measures listed in sections 8.

6.2 Environmental precautions

Try to prevent further leakage or spillage. Keep the product away from drains or water courses.

6.3 Methods and materials for containment and cleaning up

Absorb solutions with finely-powdered liquid-binding material (diatomite, universal binders); Decontaminate surfaces and equipment by scrubbing with alcohol; Dispose of contaminated material according to Section 13.

7. HANDLING AND STORAGE

7.1 Precautions for safe handling

Avoid inhalation, contact with eyes and skin. Avoid dust and aerosol formation. Use only in areas with appropriate exhaust ventilation.

7.2 Conditions for safe storage, including any incompatibilities

Keep container tightly sealed in cool, well-ventilated area. Keep away from direct sunlight and sources of ignition.

Recommended storage temperature:Powder-20°C 3 years

4°C 2 years

In solvent-80°C 6 months

-20°C 1 month

Shipping at room temperature if less than 2 weeks.

7.3 Specific end use(s)

No data available.

8. EXPOSURE CONTROLS/PERSONAL PROTECTION

8.1 Control parameters

Components with workplace control parameters

This product contains no substances with occupational exposure limit values.

8.2 Exposure controls

Engineering controls

Ensure adequate ventilation. Provide accessible safety shower and eye wash station.

Personal protective equipment

Eye protection Safety goggles with side-shields.

Hand protection Protective gloves.

Skin and body protection Impervious clothing.

Respiratory protection Suitable respirator.

Environmental exposure controls Keep the product away from drains, water courses or the soil. Clean

spillages in a safe way as soon as possible.

9. PHYSICAL AND CHEMICAL PROPERTIES

9.1 Information on basic physical and chemical properties

Appearance White to off-white (Solid)

Odor No data available

Odor threshold No data available

pH No data available

Melting/freezing point No data available

Boiling point/range No data available

Flash point No data available

Evaporation rate No data available

Flammability (solid, gas)No data available

Upper/lower flammability or explosive limits No data available

Vapor pressure No data available

Vapor density No data available

Relative density No data available

Water Solubility No data available

Partition coefficient No data available

Auto-ignition temperature No data available

Decomposition temperature No data available

Viscosity No data available

Explosive properties No data available

Oxidizing properties No data available

9.2 Other safety information

No data available.

10. STABILITY AND REACTIVITY

10.1 Reactivity

No data available.

10.2 Chemical stability

Stable under recommended storage conditions.

10.3 Possibility of hazardous reactions

No data available.

10.4 Conditions to avoid

No data available.

10.5 Incompatible materials

Strong acids/alkalis, strong oxidising/reducing agents.

10.6 Hazardous decomposition products

Under fire conditions, may decompose and emit toxic fumes.

Other decomposition products - no data available.

11.TOXICOLOGICAL INFORMATION

11.1 Information on toxicological effects

Acute toxicity

Classified based on available data. For more details, see section 2

Skin corrosion/irritation

Classified based on available data. For more details, see section 2

Serious eye damage/irritation

Classified based on available data. For more details, see section 2

Respiratory or skin sensitization

Classified based on available data. For more details, see section 2

Germ cell mutagenicity

Classified based on available data. For more details, see section 2

Carcinogenicity

IARC: No component of this product present at a level equal to or greater than 0.1% is identified as probable, possible or confirmed human carcinogen by IARC.

ACGIH: No component of this product present at a level equal to or greater than 0.1% is identified as a potential or confirmed carcinogen by ACGIH.

NTP: No component of this product present at a level equal to or greater than 0.1% is identified as a anticipated or confirmed carcinogen by NTP.

OSHA: No component of this product present at a level equal to or greater than 0.1% is identified as a potential or confirmed carcinogen by OSHA.

Reproductive toxicity

Classified based on available data. For more details, see section 2

Specific target organ toxicity - single exposure

Classified based on available data. For more details, see section 2

Specific target organ toxicity - repeated exposure

Classified based on available data. For more details, see section 2

Aspiration hazard

Classified based on available data. For more details, see section 2

12. ECOLOGICAL INFORMATION

12.1 Toxicity

No data available.

12.2 Persistence and degradability

No data available.

12.3 Bioaccumlative potential

No data available.

12.4 Mobility in soil

No data available.

12.5 Results of PBT and vPvB assessment

PBT/vPvB assessment unavailable as chemical safety assessment not required or not conducted.

12.6 Other adverse effects

No data available.

13. DISPOSAL CONSIDERATIONS

13.1 Waste treatment methods

Product

Dispose substance in accordance with prevailing country, federal, state and local regulations.

Contaminated packaging

Conduct recycling or disposal in accordance with prevailing country, federal, state and local regulations.

14. TRANSPORT INFORMATION

DOT (US)

This substance is considered to be non-hazardous for transport.

IMDG

This substance is considered to be non-hazardous for transport.

IATA

This substance is considered to be non-hazardous for transport.

15. REGULATORY INFORMATION

SARA 302 Components:

No chemicals in this material are subject to the reporting requirements of SARA Title III, Section 302.

SARA 313 Components:

This material does not contain any chemical components with known CAS numbers that exceed the threshold (De Minimis) reporting levels established by SARA Title III, Section 313.

SARA 311/312 Hazards:

No SARA Hazards.

Massachusetts Right To Know Components:

No components are subject to the Massachusetts Right to Know Act.

Pennsylvania Right To Know Components:

No components are subject to the Pennsylvania Right to Know Act.

New Jersey Right To Know Components:

No components are subject to the New Jersey Right to Know Act.

California Prop. 65 Components:

This product does not contain any chemicals known to State of California to cause cancer, birth defects, or anyother reproductive harm.

16. OTHER INFORMATION

Copyright 2017 MedChemExpress. The above information is correct to the best of our present knowledge but does not purport to be all inclusive and should be used only as a guide. The product is for research use only and for experienced personnel. It must only be handled by suitably qualified experienced scientists in appropriately equipped and authorized facilities. The burden of safe use of this material rests entirely with the user. MedChemExpress disclaims all liability for any damage resulting from handling or from contact with this product.

Caution: Product has not been fully validated for medical applications. For research use only.

Tel: 609-228-6898 Fax: 609-228-5909 E-mail: tech@https://www.sodocs.net/doc/105213756.html,

Address: 1 Deer Park Dr, Suite Q, Monmouth Junction, NJ 08852, USA

File D:\CHEM32\1\DATA\BIZ\BIZ2017-210-WJ1.D Tgt Mass (EZX): 623.00 Injection Date : 10-Feb-17, 10:31:27 Seq. Line : 0 Sample Name : BIZ2017-210-WJ1 Location : P1-E-07 Acq. Operator : GZZ_718 Inj : 0 Spec. Reported : MS Integration Inj Volume : 1 ul Acq. Method : D:\Chem32\1\METHODS\1-POS-3MIN.M

Analysis Method : D:\CHEM32\1\METHODS\HY-308_ABC10\SIM-HY-308_ABC8EPO(713.3)-H01GI03.M Catalog No : HY-P0166A Batch#23483 Easy-Access Method: '1-POS-3MIN' 623.00 Method Info : Postive,MS:100-1000,Column ID:A-RP-85,50℃

min

0.51

1.52

2.5mAU 0

2004006008001000 DAD1 B, Sig=214,4 Ref=off

1.212

1.349

min

0.51

1.5

2

2.5

10000

20000

30000400005000060000 MSD1 TIC, MS File ES-API, Pos, Scan, Frag: 70

1.395

1.453

min

0.5

1

1.52

2.5

2000

4000

6000

8000100001200014000 Ion 624, MSD1 624,Target Mass 623 +H Positive, EIC=623.7:624.7

1.330

1.391

1.459

1.4801.717

2.072

2.249

2.413

2.472

2.840

Integration Results for DAD1 B, Sig=214,4 Ref=off

RetTim Width Area Height Area% MS(+)|-------|--------|--------------|--------------|--------|------| 1.21 0.03 3.39 1.63 0.18 ND 1.35 0.02 1927.97 1358.42 99.82 623

Ret. Time: 1.39 <<<< POSITIVE SPECTRA >>>>

m/z

200

300

400

500

600

700

800

900

2000

4000600080001000012000

1400016000 ES-API Positive

661.3

312.1

625.3

624.3

623.3Ret. Time: 1.45

m/z

200

300

400

500

600

700

800

900

200400600

80010001200

1400 ES-API Positive

193.9

312.4

491.1

142.1

625.0

235.1

449.3

667.1 855.9

815.6

685.2

742.8

646.1

985.9

645.3

141.2

624.3

233.1

623.2

相关主题